Selected article for: "cardiovascular disease and respiratory disease"

Author: Keyvan Heydari; Sahar Rismantab; Amir Shamshirian; Parisa Lotfi; Nima Shadmehri; Pouya Houshmand; Mohammad Zahedi; Danial Shamshirian; Sahar Bathaeian; Reza Alizadeh-Navaei
Title: Clinical and Paraclinical Characteristics of COVID-19 patients: A systematic review and meta-analysis
  • Document date: 2020_3_30
  • ID: arhqix9h_56
    Snippet: The meta-analysis showed that the prevalence of the underlying diseases like cardiovascular disease, diabetes, cerebrovascular disease and hypertension in COVID-19 patients were 4%, 6%, 1%, 14%, respectively. However, in critically severe patients were 15%, 17%, 10%, and 31%. The prevalence of other underlying diseases like chronic liver disease and respiratory diseases were 2% and 1% whereas in severe cases, respiratory diseases prevalence is 6%.....
    Document: The meta-analysis showed that the prevalence of the underlying diseases like cardiovascular disease, diabetes, cerebrovascular disease and hypertension in COVID-19 patients were 4%, 6%, 1%, 14%, respectively. However, in critically severe patients were 15%, 17%, 10%, and 31%. The prevalence of other underlying diseases like chronic liver disease and respiratory diseases were 2% and 1% whereas in severe cases, respiratory diseases prevalence is 6% (Supplementary File and Table 2 ).

    Search related documents:
    Co phrase search for related documents